Research suggests that Shankhpushpi may have neuroprotective properties relevant to cognitive function, with the available evidence coming from a 2021 narrative review that examined medicinal herbs in the context of Alzheimer's disease and cognitive decline. The review found that certain plant-based compounds, including those from herbs in this category, demonstrate antioxidant and anti-inflammatory activity that could theoretically support brain health. However, the current evidence base is limited to review-level literature rather than direct clinical trials such as randomized controlled trials or meta-analyses specifically evaluating Shankhpushpi, which substantially constrains the conclusions that can be drawn. Studies indicate this is an emerging area of interest, in part because conventional pharmaceutical approaches to cognitive decline have faced significant setbacks, but meaningful human clinical evidence specific to Shankhpushpi and cognitive outcomes remains sparse.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Neuroprotective Herbs for the Management of Alzheimer's Disease. | Review | 2021 | Supports | 100 |